Skip to content

Jail-Based Use of Smoking Cessation Treatment Study

Reducing Tobacco-Related Health Disparities Among Incarcerated Individuals in Hennepin County

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03799315
Acronym
JUST
Enrollment
66
Registered
2019-01-10
Start date
2019-01-14
Completion date
2020-08-29
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use

Keywords

Incarceration, Smoking, Counseling, Nicotine Replacement, Disparities

Brief summary

Smoking rates remain above 60% for individuals involved in the criminal justice system and contribute to elevated mortality rates in this population. Addressing smoking disparities among justice-involved individuals is a critical public health issue in Minnesota, one of a few states with rising incarceration rates. People who are incarcerated represent the intersection of multiple high-priority populations (disproportionately African-American, Native American, low-income, homeless, on Medicaid, and suffering from mental illness and substance use disorders). This study examines the impact of a smoking cessation intervention for individuals discharged from jail to the community on smoking abstinence. Participants will be randomized to either 1) guideline-based, in-person smoking cessation counseling during incarceration, telephone counseling after incarceration, and nicotine replacement, or 2) enhanced treatment as usual. This study's findings will be used to develop a larger, multi-site study that is fully powered to measure longer-term health and smoking cessation outcomes.

Detailed description

Outcome assessments will be conducted for both arms at 1 week, 3 weeks, and 12 weeks post discharge from jail. During these assessments, seven-day point prevalence abstinence will be bio-verified with exhaled carbon monoxide, and self-reported general health, physical health, mental health, and substance use measures will also be obtained. The analysis is fully powered (i.e., power \> .8) to detect significant between group effects on the primary outcome (i.e., the longitudinal, between group effect on bio-verified seven-day point prevalence abstinence over the 3 weeks post discharge). All analyses will be conducted on the intent to treat sample and will utilize pre-specified logistic and linear regression models.

Interventions

DRUGNicotine Replacement Therapy

All participants randomized to the JUST group will receive training on proper use of nicotine lozenges to aid in smoking cessation. Upon release from jail, participants will receive 2mg nicotine lozenges.

BEHAVIORALCounseling

All participants randomized to the JUST group will receive one hour of in-person, individual, guideline-based smoking cessation counseling during their jail stay. Upon release from jail, they will receive four 30-minute counseling phone calls over 3 weeks. These phone calls will take place at 24 hours, day 7, day 14, and day 20.

Sponsors

Hennepin County Adult Detention Center
CollaboratorUNKNOWN
Brown University
CollaboratorOTHER
Hennepin Healthcare Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Use of ≥ 1 cigarette per day prior to incarceration * Expected release from the Hennepin Adult Detention Center to the community within 90 days * Age 18-64 * English fluency * Lives within 20 minutes of Hennepin County Medical Center and has no plans to move away from area for 4 months * Willing to attempt quitting or reducing smoking at discharge * Has a telephone * Cleared for nicotine lozenge safety by jail health care provider and willing to use at discharge

Exclusion criteria

* Active tuberculosis * Current mental health crisis (i.e., currently experiencing significant mania, psychosis, or suicidality) * Unable to ambulate independently * Acute medical condition that would impair participant's ability to follow-up for assessments * Expected discharge to a control institutional setting (e.g., locked state mental health facility or prison) * Active pregnancy * Heart attack within the last two weeks

Design outcomes

Primary

MeasureTime frameDescription
Bioverified 7-day point prevalence abstinence from smokingOver 3 weeksBioverified 7-day point prevalence abstinence from smoking

Secondary

MeasureTime frameDescription
Time to Relapse3 weeks, 12 weeksDays to first relapse
Time to Lapse1 week, 3 weeks, 12 weeksDays to first lapse (i.e., any cigarette use, even a puff)
Bio-verified 7-day point prevalence abstinence from smokingOver 12 weeksBioverified 7-day point prevalence abstinence from smoking
Health-related quality of life1 week, 3 weeks, 12 weeksSelf-Reported health using the SF-12 total score and physical and mental health composite scores. Lower scores indicate worse health.
Depressive symptoms1 week, 3 weeks, 12 weeksThe 10 item Center for Epidemiologic Studies Depression Scale (CESD-10) ranges from 0-30 with higher scores indicating higher depression symptoms.
Self-Reported Affect1 week, 3 weeks, 12 weeks10-item Positive and Negative Affect Scales (PANAS). The 5-item positive affect scale on the PANAS ranges from 5-25 with higher scores indicating greater positive affect. The 5-item negative affect scale on the PANAS ranges from 5-25 with higher scores indicating greater negative affect.
Health care utilization1 week, 3 weeks, 12 weeksSelf-reported hospitalizations and use of the emergency department
Substance abuse1 week, 3 weeks, 12 weeksSelf-reported substance abuse using the Drug Abuse Screening Test-10. Higher scores indicate more severe drug abuse.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026